PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.89%
Revenue growth above 1.5x QCOM's 5.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.06%
Gross profit growth above 1.5x QCOM's 7.27%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
32.73%
EBIT growth above 1.5x QCOM's 2.33%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
32.73%
Operating income growth above 1.5x QCOM's 2.33%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
308.03%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
316.22%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
316.67%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-2.02%
Share reduction while QCOM is at 1.16%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.98%
Reduced diluted shares while QCOM is at 1.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.07%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
14.72%
OCF growth under 50% of QCOM's 49.16%. Michael Burry might suspect questionable revenue recognition or rising costs.
77.85%
FCF growth 75-90% of QCOM's 90.08%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
50.46%
10Y revenue/share CAGR under 50% of QCOM's 645.60%. Michael Burry would suspect a lasting competitive disadvantage.
109.30%
5Y revenue/share CAGR at 75-90% of QCOM's 133.22%. Bill Ackman would encourage strategies to match competitor’s pace.
75.93%
3Y revenue/share CAGR 1.25-1.5x QCOM's 66.75%. Bruce Berkowitz might see better product or regional expansions than the competitor.
278.11%
10Y OCF/share CAGR under 50% of QCOM's 1177.04%. Michael Burry would worry about a persistent underperformance in cash creation.
25.75%
Below 50% of QCOM's 575.97%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
88.16%
3Y OCF/share CAGR above 1.5x QCOM's 45.65%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2966.45%
Below 50% of QCOM's 23895.59%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1497.30%
5Y net income/share CAGR above 1.5x QCOM's 260.80%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2095.75%
3Y net income/share CAGR above 1.5x QCOM's 445.91%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
191.78%
Below 50% of QCOM's 891.64%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.42%
Below 50% of QCOM's 131.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
30.08%
Below 50% of QCOM's 81.00%. Michael Burry suspects a serious short-term disadvantage in building book value.
42.42%
Dividend/share CAGR of 42.42% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
46.49%
Dividend/share CAGR of 46.49% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
41.39%
3Y dividend/share CAGR of 41.39% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.29%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
7.14%
Inventory growth well above QCOM's 11.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.46%
Asset growth 1.25-1.5x QCOM's 10.65%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
16.14%
BV/share growth above 1.5x QCOM's 10.65%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-86.48%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.56%
R&D dropping or stable vs. QCOM's 14.71%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-0.71%
We cut SG&A while QCOM invests at 10.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.